• Latest Posts

Spinoff Biohaven launches with $258M and “incredible pipeline”

NeuShen Therapeutics closes $20M pre-A financing

Research identifies new treatment target for CNS injury and neurological disease

Emyria starts program with neuroscience drug discovery CRO

NodThera reveals positive results for inflammasome inhibitors

FDA clears Cellenkos ALS drug for trial

ADVERTISEMENT

Collaboration to explore gene therapy products for neurodegenerative disorders

First patient enrolled in phase 3 study of drug for Charcot-Marie-Tooth disease

Ionis presents positive study results at International Symposium on amyloidosis

Scientists unravel mystery behind neurodegenerative disease protein

Gate Neurosciences emerges from stealth to tackle CNS diseases

Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases

ADVERTISEMENT